Revenue · 2019–2025

Keros Therapeutics revenue

$244M+6,775.0% · FY2025

Keros Therapeutics (KROS) reported $244M in revenue for fiscal 2025, +6,775.0% year on year.

$10.0M2019$02020$20.1M2021$02022$151,0002023$3.6M2024$244M2025
Keros Therapeutics — Revenue, 2019–2025
Fiscal yearRevenueChangeFiling
FY20252025-12-31$244M+6,775.0%Open →
FY20242024-12-31$3.6M+2,251.0%Open →
FY20232023-12-31$151,000+$151,000Open →
FY20222022-12-31$0−100.0%Open →
FY20212021-12-31$20.1M+$20.1MOpen →
FY20202020-12-31$0−100.0%Open →
FY20192019-12-31$10.0M—Open →

Revenue — Revenue is total net sales for the fiscal year, taken from each company's own annual filing.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2019–2025 compound annual growth +70.3%

Revenue at companies of similar size

Full ranking by revenue →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Keros Therapeutics revenue |url=https://companiesranked.com/en/company/keros-therapeutics/revenue |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Keros Therapeutics revenue. CompaniesRanked. https://companiesranked.com/en/company/keros-therapeutics/revenue

BibTeX

@misc{companiesranked-en-company-keros-therapeutics-revenue-2026,
  author       = {{CompaniesRanked}},
  title        = {{Keros Therapeutics revenue}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/keros-therapeutics/revenue}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-K · 0001664710-26-000018 · March 4, 2026

{{cite web |title=Keros Therapeutics revenue — 10-K (0001664710-26-000018) |url=https://www.sec.gov/Archives/edgar/data/1664710/000166471026000018/kros-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-03-04}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Keros Therapeutics overview